TABLE 1.
Baseline clinical characteristics of the women included.
| Total n = 84 | Adenomyosis n = 38 | Controls n = 46 | p‐value | |
|---|---|---|---|---|
| Age in years, mean (SD) | 37.6 (4.9) | 38.0 (4.9) | 37.1 (4.9) | 0.38 |
| BMI in kg/m2, mean (SD) | 24.4 (4.0) | 24.4 (4.2) | 24.4 (3.9) | 0.98 |
| Caucasian, n (%) | 72 (85.7) | 34 (89.5) | 42 (91.3) | 0.23 |
| Nulliparity, n (%) | 40 (47.6) | 27 (71.1) | 13 (28.2) | <0.001 |
| Hormonal treatment, n (%) | 68 (81.0) | 31 (81.6) | 37 (80.4) | 0.56 |
| Pain scores, NRS (0–10), mean (SD) | ||||
| Dysmenorrhea | 4.5 (3.6) | 5.7 (3.9) | 3.6 (3.1) | 0.007 |
| NCCPP | 2.1 (2.9) | 4.2 (3.1) | 0.4 (1.2) | <0.001 |
| HMB, n (%) | 20 (23.8) | 20 (52.6) | 0 (0.0) | <0.001 |
| Infertility | 12 (14.3) | 12 (31.6) | 0 (0.0) | <0.001 |
Abbreviations: BMI, body mass index; HMB, heavy menstrual bleeding; NCCPP, non‐cyclic chronic pelvic pain; NRS, numerical rating scale.
Note: Bold values indicate statistically significant results (p < 0.05).